Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


Australian Household Spending Rebounds Strongly in May as Travel and Dining Drive Consumer Growth
Gold Drops Below $4,000 as Strong US Dollar and Fed Rate Hike Expectations Pressure Bullion
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies
South Korea Stocks Tumble as AI-Fueled Rally Faces Profit-Taking Pressure
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
Singapore Inflation Stays Muted in May as Core CPI Misses Forecasts Ahead of MAS Review
Bessent Says U.S. Must Strengthen Supply Chains and Economic Security
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast
U.S. Dollar Reaches One-Year High as Tech Sell-Off and Fed Rate Hike Expectations Support Demand
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 



